Phase 4 N=34 Effect of Vitamin D Supplementation on Muscle Mass and Function
Obesity · Insulin Resistance · Inflammation
Primary: Muscle Function — 1.14; 1.50 kilograms
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=1,761 A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh
Influenza
Primary: Percentage of Participants With Symptomatic, Laboratory-confirmed Influenza Virus Infection (Vaccine-matched Strains). — 6.7; 15.8 percentage of participants — p=<0.0001
Phase 2 N=20 Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Childhood Hepatocellular Carcinoma · Papillary Thyroid Cancer · Previously Treated Childhood Rhabdomyosarcoma
Primary: Objective Response by RECIST Criteria v 1.1 — 10; 10; 0; 0 participants
Phase 2 N=20 Artificial Pancreas Control System in an Outpatient Setting
Type 1 Diabetes Mellitus
Primary: Verification of the Automation and Telemetry Components — 16.5 failures
Phase 3 N=166 DE-111 Against Timolol Ophthalmic Solution 0.5%
Open Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Mean Diurnal IOP (Intraocular Pressure) at End of Study — -3.2; -1.7 mmHg — p=< 0.001
N/A N=31 Improving Outcomes After PICU Admission: A Pilot Study
Critical Illness
Primary: The Number of Feasibility Criteria Successfully Met — 3; 1 Number of criteria successfully met
Phase 2 N=44 Effectiveness of Minimally Invasive Total Knee Replacement in Improving Rehabilitation and Function
Osteoarthritis
Primary: Quadriceps Muscle Force — 1.27; 1.37; 0.79; 0.66 Nm/kg — p=0.07
N/A N=314 Clinical Trial of Several Contact Lenses in Extended Wear
Myopia
Primary: Incidence of Corneal Infiltrative Events — 31; 16; 10; 8 percentage of participants
Early Phase 1 N=12 The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
Asthma
Primary: The Primary Outcome Measure for This Study is the Number of Sputum Myeloid Dendritic Cells — 32800; 89100 number of cells/g of sputum
Phase 4 N=7 Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?
Mild Intermittent Asthma
Primary: The Magnitude of the Early Asthmatic Response, Expressed as a Percentage Change in FEV1. — -30.5; -39.0; -31.9 percentage fall FEV1
Phase 2 N=20 Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Adenocarcinoma of the Prostate · Recurrent Prostate Cancer · Stage I Prostate Cancer
Primary: Cell Proliferation in the Prostatectomy Tissue as Assessed by Ki67 Expression Using Immunohistochemistry (IHC) — 6.5; 3.67 % positively stained nuclei — p=0.23
Phase 2 N=268 Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
Pain · Anxiety
Primary: Change From Baseline in Faces Pain Scale Revised (FPS-R) at 30 Minutes After IV Cannulation — -3.544; -3.436 units on a scale
Phase 2 N=12 Effects Of tDCS With Physical Therapy On Rehabilitation In Parkinson's Disease
Parkinson Disease
Primary: Change From Unified Parkinson´s Disease Rating Scale - UPDRS — 24; 30; 21.2; 21.8 units on a scale
Phase 3 N=418 A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Percentage of Participants With American College of Rheumatology (ACR) 50 Response at Week 24 — 73.23 percentage of participants
N/A N=40 fMRI Cholinergic Mechanisms in Schizophrenia
Schizophrenia
Primary: Neuronal Response During Sensory Gating — .12; .11 % BOLD signal